![Richard Colvin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Colvin
No open positions remaining
Profile
Richard Colvin formerly worked at Novartis, Inc., as Executive Director-Translational Medicine from 2014 to 2018 and bluebird bio, Inc., as VP & Head-Severe Genetic Diseases Clinical R&D from 2020 to 2021.
Dr. Colvin received his undergraduate degree from Cornell University and doctorate degree from Duke University School of Medicine.
Former positions of Richard Colvin
| Companies | Position | End |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 2018-09-30 |
| GENETIX BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Richard Colvin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Richard Colvin
